FY2023 Q1
Financial Briefing Material
August 9, 2023
JMDC Inc.
Section 1
FY2023 Q1 Performance Report
2
FY2023 Q1: Summary of Consolidated Performance
Although profit (EBITDA) for this Q1 started off rather slowly, we understand that this is not a problem for the full year, g iven the business structure that is heavily weighted toward the second half of the year. In addition, each of the profits below operating profi t increased significantly due to a gain from the transfer of a subsidiary.
(Unit: Million JPY)
Revenue
Operating profit (Rate)
Profit before taxes (Rate)
Profit attributable to
owners of parent (Rate)
EBITDA (Margin)
FY2022 Q1 | FY2023 Q1 | Y-o-Y | |||
5,776 | 6,698 | +16% | |||
1,081 | 2,546 | +136% | |||
(19%) | (38%) | ||||
1,120 | 2,552 | +128% | |||
(19%) | (38%) | ||||
765 | 2,040 | +167% | |||
(13%) | (31%) | ||||
1,521 | 1,679 | +10% | |||
(26%) | (25%) | ||||
3
Note: IFRS-based
EBITDA: Operating profit + Depreciation and amortization costs ± Other profits and/or losses, EBITDA margin: EBITDA/Revenue
FY2023 Q1: Quarterly Consolidated Revenue/EBITDA
Given the strong performance in Q1 of the previous fiscal year, we believe that this Q1 is off to a good start in terms of bo th revenue and profit.
Quarterly Trends of Consolidated Revenue | Quarterly Trends of Consolidated EBITDA/margin | |||
(Unit: Million JPY) | (Unit: Million JPY and %) | |||
EBITDA | ||||
margin | ||||
26 | 26 | 25 |
+ 16% | 8,266 | |||||||
7,482 | 6,698 | |||||||
6,128 | 6,135 | 6,283 | ||||||
5,776 | ||||||||
5,020 | ||||||||
4,530 | ||||||||
Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | Q1 |
FY2021 | FY2022 | FY2023 |
+ 10% | ||||||||
2,376 | 2,384 | |||||||
EBITDA | 2,107 | 1,831 | ||||||
1,521 | 1,679 | |||||||
1,308 | 1,434 | |||||||
1,164 | ||||||||
Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | Q1 |
FY2021 | FY2022 | FY2023 | ||||||
Full-year EBITDA margin | Full-year EBITDA margin | Full-year EBITDA margin | ||||||
29% | 28% | 30% |
4
Note: IFRS-based
EBITDA: Operating profit + Depreciation and amortization costs ± Other profits and/or losses, EBITDA margin: EBITDA/Revenue
FY2023 Q1: Performance by Segment
Revenue and profit grew in all segments.
(Unit: Million JPY) | FY2022 Q1 | FY2023 Q1 | Y-o-Y | ||
Healthcare-Big Data
Tele-medicine
Dispensing Pharmacy
Support
Adjustment
Revenue | 3,749 | 4,497 | +20% |
EBITDA | 1,124 | 1,294 | +15% |
(Margin) | (30%) | (29%) | |
Revenue | 1,175 | 1,307 | +11% |
EBITDA | 439 | 448 | +2% |
(Margin) | (37%) | (34%) | |
Revenue | 910 | 969 | +7% |
EBITDA | 47 | 87 | +84% |
(Margin) | (5%) | (9%) | |
Revenue | -58 | -76 | - |
EBITDA | -90 | -151 | - |
5
Note: IFRS-based
EBITDA: Operating profit + Depreciation and amortization costs ± Other profits and/or losses, EBITDA margin: EBITDA/Revenue